Thermo Fisher Scientific, the giant in the scientific instrument industry with $24.6 billion in sales last year, held its 2019 Analyst Meeting earlier this week. At the event, the company emphasized its broad product offerings, operational scale and market opportunities, with contributions in each of these areas from across its business segments. Highlighting these segments’ […]
An important aspect of drug discovery and design is QSAR, or Quantitative Structure Activity Relationship studies. QSAR attempts to create mathematical models that illustrate the relationship of the chemical and physical properties of compounds to their chemical structures. QSAR is commonly used for the prediction of pharmacokinetic properties, such as absorption, distribution, metabolism and excretion […]
In a blog published in June last year (see Tariffs to Affect US Imports of Chromatographs and Spectrometers from China), IBO examined the possible early implications of new US tariffs on imports from China for chromatographs (Harmonized Trade Schedule Code 9027.20) and spectrometers (Harmonized Trade Schedule Code 9027.30) imports, both of which are subject to […]
Last month, the European Parliament’s Policy Department for Economic, Scientific and Quality of Life Policies released a study on the progress, current status and future of Europe’s R&D. The study was requested by the European Parliament’s Committee on Industry, Research and Energy. The report provided information on science and technology (S&T) developments over the past […]
In fiscal year 2019 (FY19) (ending September 30), the budget for the NIH, the largest funder of biomedical research in the US, totaled $39,308 million, a 5.4% increase. But how is the NIH spending this money? One way to measure the spending is by disease category. The NIH recently updated its data on its total […]
Thermo Fisher Scientific Details Future at Analyst Meeting
Thermo Fisher Scientific, the giant in the scientific instrument industry with $24.6 billion in sales last year, held its 2019 Analyst Meeting earlier this week. At the event, the company emphasized its broad product offerings, operational scale and market opportunities, with contributions in each of these areas from across its business segments. Highlighting these segments’ […]
IBO Dives into Deep Learning with Schrödinger
An important aspect of drug discovery and design is QSAR, or Quantitative Structure Activity Relationship studies. QSAR attempts to create mathematical models that illustrate the relationship of the chemical and physical properties of compounds to their chemical structures. QSAR is commonly used for the prediction of pharmacokinetic properties, such as absorption, distribution, metabolism and excretion […]
US Chromatograph and Spectrometer Imports from China Decline in 2018
In a blog published in June last year (see Tariffs to Affect US Imports of Chromatographs and Spectrometers from China), IBO examined the possible early implications of new US tariffs on imports from China for chromatographs (Harmonized Trade Schedule Code 9027.20) and spectrometers (Harmonized Trade Schedule Code 9027.30) imports, both of which are subject to […]
European Parliament Study Examines EU’s R&D Standing Compared to the US and China
Last month, the European Parliament’s Policy Department for Economic, Scientific and Quality of Life Policies released a study on the progress, current status and future of Europe’s R&D. The study was requested by the European Parliament’s Committee on Industry, Research and Energy. The report provided information on science and technology (S&T) developments over the past […]
Clinical Research Leads NIH Funding in Fiscal 2019
In fiscal year 2019 (FY19) (ending September 30), the budget for the NIH, the largest funder of biomedical research in the US, totaled $39,308 million, a 5.4% increase. But how is the NIH spending this money? One way to measure the spending is by disease category. The NIH recently updated its data on its total […]